Clinuvel Pharmaceuticals Market Cap

Clinuvel Pharmaceuticals has a market cap or net worth of $339.05 million as of May 27, 2025. Its market cap has decreased by -32.84% in one year.

Market Cap

339.05M

Enterprise Value

210.67M

Revenue

56.33M

Ranking

n/a

PE Ratio

14.13

Stock Price

$6.75

Market Cap Chart

Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 2.79M to 339.05M, an increase of 12,057.12%. That is a compound annual growth rate of 21.84%.

Market Cap History

Date	Market Cap	% Change
May 27, 2025	343.28M	-7.91%
Dec 31, 2024	372.77M	-31.82%
Dec 29, 2023	546.72M	-24.87%
Dec 30, 2022	727.74M	-25.56%
Dec 31, 2021	977.57M	14.90%
Dec 31, 2020	850.82M	-13.85%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.63B
Veradigm	747.23M
Nika Pharmaceuticals	672.83M
Tian'an Technology Group	591.73M
Elite Pharmaceuticals	565.54M
Glass House Brands	452.21M
CytoDyn	423.89M
Northwest Biotherapeutics	399.66M

Market Cap Rankings